Tolerance and immunogenicity of ProCervix, a HPV-16 & 18 therapeutic vaccine, in HPV infected women
Latest Information Update: 10 Jun 2016
At a glance
- Drugs GTL 001 (Primary)
- Indications Cervical cancer; Cervical dysplasia; Human papillomavirus infections
- Focus Adverse reactions
- Sponsors GENTICEL
- 01 Jun 2016 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 01 Jun 2016 Results published online in Clinical Cancer Research, according to a Genticel media release.
- 01 Jun 2016 Results published in a Genticel media release.